NSN 6505-01-701-9015, 6505017019015
FENTANYL CITRATE INJECTION

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 017019015
Codification Country: United States
Item Name Code: INC 30015
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Request Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-701-9015

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-701-9015

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-701-9015

National Stock Number (NSN) 6505-01-701-9015, or NIIN 017019015, (fentanyl citrate injection) was assigned June 15, 2022 in the Federal Logistics Information System (FLIS). This NSN does not replace any other NSNs.

There are 4 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 2 suppliers. Today, 2 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 2 suppliers are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years.

There has been very little demand for this national stock number. The demand for this NSN originated from less than 5 countries.

This NSN is assigned to Item Name Code (INC) 30015. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505017019015 does not contain precious metals.

This information was last updated on Jul 01, 2025.

Technical Characteristics

SPECIAL FEATURES: (FEAT) FENTANYL CITRATE INJECTION IS INDICATED FOR ANALGESIC ACTION OF SHORT DURING THE ANESTHETIC PERIODS, PREMEDICATION, INDUCTION AND MAINTENANCE IN THE IMMEDIATE POSTOPERATIVE PERIOD (RECOVERY ROOM); USE AS AN OPIOID ANALGESIC SUPPLEMENT IN GENERAL OR REGIONAL ANESTHESIA; ERALADMINISTRATION WITH A NEUROLEPTIC AS AN ANESTHETIC PREMEDICATION, FOR THE INDUCTION OF ANESTHESIA AND AS AN ADJUNCT IN THE MAINTENANCE OF GENERAL AND REGIONAL ANESTHESIA; USE AS AN ANESTHETIC AGENT WITH OXYGEN IN SELECTED HIGH RISK PATIENTS, SUCH AS THOSE UNDERGOING OPEN HEART SURGERY OR CERTAIN COMPLICATED NEUROLOGICAL OR ORTHOPEDIC PROCEDURES; PROTECT FROM LIGHT. KEEP COVERED IN CARTON UNTIL TIME OF USE. STORE AT 68 TO 77 F; EXCURSIONS PERMITTED TO 59 TO 86 F; CONTAINS NO PRESERVATIVE. DISCARD ANY UNUSED CONTENTS. NDC 6332380605 IS 250 MCG IN 5ML. C-II DRUG.
SECONDARY CONTAINER TYPE: (CQGK) CASE
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) FENTANYL CITRATE INJECTION. (25 VIALS (5ML) PER CARTON)
ADMINISTRATION: (CSGS) INTRAMUSCULAR AND INTRAVENOUS
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) FETANYL CITRATE INJECTION USP 50MCG/ML (250MCG/5ML) VIAL.
PRIMARY CONTAINER CONTENT QUANTITY: (CRLK) 5.0 MILLILITERS
TOTAL PRIMARY CONTAINER QUANTITY: (CSCW) 25
ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 2.50 MICROGRAMS FENTANYL CITRATE EQUIVALENT PER 5 MILLILITERS
PRIMARY CONTAINER TYPE: (CQCT) VIAL
CONTROLLED SUBSTANCE CLASSIFICATION: (CRYC) SCHEDULE II